Chronic Lymphocytic Leukemia Best of ASH 2016 in CLL
Anthony Mato, MD, considers advances in chronic lymphocytic leukemia therapy in the context of advances presented at 2016 ASH.
Access Restricted
You must provide the password to continue.
Anthony Mato, MD, considers advances in chronic lymphocytic leukemia therapy in the context of advances presented at 2016 ASH.
You must provide the password to continue.
BROADCASTMED